Integral Derivatives’s MetLife MET Stock Holding History

Integral Derivatives’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	$1.09M	Sell	23,800 -6,200	-21%	-$301K	0.03%	219
2017 Q4	$1.52M	Sell	30,000 -5,000	-14%	-$263K	0.03%	362
2017 Q3	$1.82M	Sell	35,000 -23,681	-40%	-$1.15M	0.03%	339
2017 Q2	$2.87M	Buy	58,681 +29,733	+103%	+$1.38M	0.06%	224
2017 Q1	$1.36M	Sell	28,948 -4,375	-13%	-$209K	0.02%	430
2016 Q4	$1.6M	Buy	33,323 +1,009	+3%	+$46.3K	0.03%	376
2016 Q3	$1.28M	Buy	32,314 +4,040	+14%	+$152K	0.03%	372
2016 Q2	$1M	Sell	28,274 -5,610	-17%	-$219K	0.02%	418
2016 Q1	$1.33M	Sell	33,884 -449	-1%	-$16.8K	0.04%	306
2015 Q4	$1.48M	Buy	34,333 +3,254	+10%	+$143K	0.04%	345
2015 Q3	$1.31M	Sell	31,079 -4,713	-13%	-$220K	0.04%	429
2015 Q2	$1.79M	Buy	35,792 +12,342	+53%	+$584K	0.05%	350
2015 Q1	$1.06M	Hold	23,450	–	–	0.02%	496
2014 Q4	$1.13M	Hold	23,450	–	–	0.02%	630
2014 Q3	$1.12M	Buy	+23,450	New	+$1.14M	0.02%	657
2014 Q1	–	Sell	-30,294	Closed	-$1.46M	–	1493
2013 Q4	$1.46M	Buy	+30,294	New	+$1.36M	0.02%	632

Other funds holding MET

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Integral Derivatives's MET Position: Q3 2017 in Review

Integral Derivatives sold out of MetLife (MET) in Q3 2017, closing a stake of 14,421 shares — an estimated $702K sold.

Integral Derivatives first reported a position in MET in Q4 2013 and held it in 10 quarters. The position peaked at $1.18M in Q4 2016. 985 funds tracked by Wall St. Rank hold MET as of Q3 2017.

Integral Derivatives reported no remaining MetLife position as of Q3 2017 after selling out during the quarter.
Integral Derivatives sold 14,421 MetLife shares in Q3 2017, an estimated $702K.
Integral Derivatives first reported a position in MetLife in Q4 2013 and held it in 10 quarters.
Integral Derivatives's MetLife position peaked at $1.18M in Q4 2016.
985 funds tracked by Wall St. Rank held MetLife as of Q3 2017.

Based on Integral Derivatives's 13F filing for Q3 2017, filed 14 Nov 2017.